1. Home
  2. HALO vs LCID Comparison

HALO vs LCID Comparison

Compare HALO & LCID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • LCID
  • Stock Information
  • Founded
  • HALO 1998
  • LCID 2007
  • Country
  • HALO United States
  • LCID United States
  • Employees
  • HALO N/A
  • LCID N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • LCID Auto Manufacturing
  • Sector
  • HALO Health Care
  • LCID Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • LCID Nasdaq
  • Market Cap
  • HALO 7.4B
  • LCID 8.1B
  • IPO Year
  • HALO N/A
  • LCID N/A
  • Fundamental
  • Price
  • HALO $52.80
  • LCID $2.16
  • Analyst Decision
  • HALO Buy
  • LCID Hold
  • Analyst Count
  • HALO 9
  • LCID 9
  • Target Price
  • HALO $63.56
  • LCID $3.00
  • AVG Volume (30 Days)
  • HALO 2.9M
  • LCID 140.8M
  • Earning Date
  • HALO 08-05-2025
  • LCID 08-04-2025
  • Dividend Yield
  • HALO N/A
  • LCID N/A
  • EPS Growth
  • HALO 55.40
  • LCID N/A
  • EPS
  • HALO 3.76
  • LCID N/A
  • Revenue
  • HALO $1,084,306,000.00
  • LCID $870,140,000.00
  • Revenue This Year
  • HALO $25.77
  • LCID $76.52
  • Revenue Next Year
  • HALO $18.01
  • LCID $95.37
  • P/E Ratio
  • HALO $14.37
  • LCID N/A
  • Revenue Growth
  • HALO 25.64
  • LCID 40.67
  • 52 Week Low
  • HALO $42.01
  • LCID $1.93
  • 52 Week High
  • HALO $70.51
  • LCID $4.43
  • Technical
  • Relative Strength Index (RSI)
  • HALO 50.36
  • LCID 48.77
  • Support Level
  • HALO $51.06
  • LCID $1.98
  • Resistance Level
  • HALO $54.25
  • LCID $2.23
  • Average True Range (ATR)
  • HALO 1.22
  • LCID 0.10
  • MACD
  • HALO 0.23
  • LCID 0.01
  • Stochastic Oscillator
  • HALO 84.97
  • LCID 70.97

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

Share on Social Networks: